| Автор | Martino, G |
| Автор | Furlan, R |
| Автор | Galbiati, F |
| Автор | Poliani, P, L |
| Автор | Bergami, A |
| Автор | Grimaldi, L, ME |
| Автор | Adorini, L |
| Автор | Comi, G |
| Дата выпуска | 1998 |
| dc.description | A successful gene therapy approach in organ-specific autoimmune diseases, such as multiple sclerosis (MS), encompasses the inhibition of the autoreactive T cells or the modification of the target organ cells by the introduction of exogenous `protective' genes. In MS, an autoimmune disease of the central nervous system (CNS), the inciting autoantigen is still unknown and therefore the isolation of autoreactive T cells may only be inferential. At present, gene therapy approaches in MS should therefore aim to the modification of the target organ. Possible candidate genes to be transferred within the CNS of MS patients are those coding for anti-inflammatory cytokines (i.e. interleukin-4, interleukin-10, transforming growth factor b) which have been shown to ameliorate demyelinating diseases at least in experimental models. However, a limiting factor for this therapy is the difficulty to reach the CNS. A gene therapy approach using viral vectors able to infect post-mitotic cells, such as those present within the CNS, without inducing toxic reactions, may overcome this limitation. We propose to use non-replicative herpetic vectors, which represent a viable gene-transfer alternative to the classical retroviral and adenoviral vectors. Key advantages are their size, able to accommodate multiple foreign genes, and their ability to infect post-mitotic cells such as those present within the CNS. We first transferred a gene coding for interleukin-4 within the CNS of mice undergoing experimental allergic encephalomyelitis, an animal model for MS, using non-replicative Herpes Simplex Virus type 1- derived vectors. We found that this approach ameliorates the disease course and delays the disease onset. The establishment of this technique to deliver anti-inflammatory cytokines within the CNS using herpetic vectors should clarify the role of individual cytokines in the demyelinating process and allow assessment of whether gene therapy using herpetic vectors is a feasible and safe approach to treat human demyelinating disorders. |
| Издатель | Sage Publications |
| Тема | multiple sclerosis |
| Тема | experimental demyelination |
| Тема | cytokines |
| Тема | gene therapy |
| Тема | herpetic vectors |
| Название | A gene therapy approach to treat demyelinating diseases using nonreplicative herpetic vectors engineered to produce cytokines |
| Тип | Journal Article |
| DOI | 10.1177/135245859800400325 |
| Print ISSN | 1352-4585 |
| Журнал | Multiple Sclerosis |
| Том | 4 |
| Первая страница | 222 |
| Последняя страница | 227 |
| Аффилиация | Martino, G, Exp. Neuroimmunotherapy Unit-DIBIT, San Raffaele Scientific Institute, Via Olgettina 58, 20132 Milano, Italy, Dept. of Neurology, University of Milano, San Raffaele Scientific Institute, Via Olgettina 60, 20132 Milano, Italy |
| Аффилиация | Furlan, R, Exp. Neuroimmunotherapy Unit-DIBIT, San Raffaele Scientific Institute, Via Olgettina 58, 20132 Milano, Italy |
| Аффилиация | Galbiati, F, Roche Milano Ricerche, Via Olgettina 58, 20132 Milano, Italy |
| Аффилиация | Poliani, P, L, Exp. Neuroimmunotherapy Unit-DIBIT, San Raffaele Scientific Institute, Via Olgettina 58, 20132 Milano, Italy |
| Аффилиация | Bergami, A, Exp. Neuroimmunotherapy Unit-DIBIT, San Raffaele Scientific Institute, Via Olgettina 58, 20132 Milano, Italy |
| Аффилиация | Grimaldi, L, ME, Dept. of Neurology, University of Milano, San Raffaele Scientific Institute, Via Olgettina 60, 20132 Milano, Italy, Neuroimmunology Unit - DIBIT, San Raffaele Scientific Institute, Via Olgettina 58, 20132 Milano, Italy |
| Аффилиация | Adorini, L, Roche Milano Ricerche, Via Olgettina 58, 20132 Milano, Italy |
| Аффилиация | Comi, G, Dept. of Neurology, University of Milano, San Raffaele Scientific Institute, Via Olgettina 60, 20132 Milano, Italy |
| Выпуск | 3 |
| Библиографическая ссылка | Martin R, McFarland HF, McFarlin DE. (1992) Immunological aspects of demyelinating diseases. Annu Rev Immunol 10: 153-187. |
| Библиографическая ссылка | Steinman L. (1996) A few autoreactive cells in an autoimmune infiltrate control a vast population of nonspecific cells: a tale of smart bombs and the infantry. Proc Natl Acad Sci USA 93: 2253-2256. |
| Библиографическая ссылка | Goverman Jet al. (1993) Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity. Cell 72: 551-560. |
| Библиографическая ссылка | Lafaille JJ, Nagashima K, Katsuki M, Tonegawa S. (1994) High incidence of spontaneous autoimmune encephalomyelitis in immunodeficient anti-myelin basic protein T cell receptor transgenic mice. Cell 78: 399-408. |
| Библиографическая ссылка | Unutmaz D, Pileri P, Abrignani S. (1994) Antigen-independent activation of naive and memory resting T cells by a cytokine combination. J Exp Med 180: 1159-1164. |
| Библиографическая ссылка | Tough DF, Borrow P, Sprent J. (1996) Induction of bystander T cell proliferation by viruses and type I interferon in vivo. Science 272: 1947-1950. |
| Библиографическая ссылка | Panitch HS, Hirsch RL, Haley AS, Johnson KP. (1987) Exacerbations of multiple sclerosis in patients treated with gamma interferon. Lancet 1: 893-895. |
| Библиографическая ссылка | Panitch HS, Hirsch RL, Schindler J, Johnson KP. (1987) Treatment of multiple sclerosis with gamma interferon: exacerbations associated with activation of the immune system. Neurology 37: 1097-1102. |
| Библиографическая ссылка | Selmaj K, Raine CS, Cannella B, Brosnan CF. (1991) Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. J Clin Inv 87: 949-954. |
| Библиографическая ссылка | Martino G, Grimaldi LME. (1996) The pathogenetic role of interferon-g in multiple sclerosis. In: Reder A (ed). Interferon therapy of multiple sclerosis. Marcel Dekker: New York pp 194-213. |
| Библиографическая ссылка | Beck Jet al. (1988) Increased production of interferon gamma and tumor necrosis factor precedes clinical manifestation in multiple sclerosis: do cytokines trigger off exacerbations? Acta Neurol Scand 78: 318-323. |
| Библиографическая ссылка | Mosmann TRet al. (1986) Two types of murine helper T cell clone. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 136: 2348-2357. |
| Библиографическая ссылка | Del Prete GFet al. (1991) Purified protein derivative of Mycobacterium tuberculosis and excretory-secretory antigen(s) of Toxocara canis expand in vitro human T cells with stable and opposite (type 1 T helper or type 2 T helper) profile of cytokine production. J Clin Inv 88: 346-350. |
| Библиографическая ссылка | Abbas AK, Murphy KM, Sher A. (1996) Functional diversity of helper T lymphocytes. Nature 383: 787-793. |
| Библиографическая ссылка | Leonard JP, Waldburger KE, Goldman SJ. (1995) Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12. J Exp Med 181: 381-386. |
| Библиографическая ссылка | Trembleau Set al. (1995) Interleukin 12 administration induces T helper type 1 cells and accelerates autoimmune diabetes in NOD mice. J Exp Med 181: 817-821. |
| Библиографическая ссылка | Germann Tet al. (1995) Administration of interleukin 12 in combination with type II collagen induces severe arthritis in DBA/1 mice. Proc Natl Acad Sci USA 92: 4823-4827. |
| Библиографическая ссылка | Romagnani S. (1994) Lymphokine production by human T cells in disease states. Annu Rev Immunol 12: 227-257. |
| Библиографическая ссылка | Trembleau S, Germann T, Gately MK, Adorini L. (1995) The role of IL-12 in the induction of organ-specific autoimmune diseases. Immunol Today 16: 383-386. |
| Библиографическая ссылка | The IFNB Multiple Sclerosis Group. (1993) Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. Neurology43: 655-661. |
| Библиографическая ссылка | Weinstock-Guttman B, Ransohoff RM, Kinkel RP, Rudick RA. (1995) The interferons: biological effects, mechanisms of action, and use in multiple sclerosis. Ann Neurol 37: 7-15. |
| Библиографическая ссылка | Hintzen RQ, Polman CH. (1997) Th cell modulation in multiple sclerosis. Immunol Today 18: 507-508 (Letter). |
| Библиографическая ссылка | The IFNB Multiple Sclerosis Study Group and the University of British Columbia MS/MRI Analysis Group. (1996) Neutralizing antibodies during treatment of multiple sclerosis with interferon beta-1b: experience during the first three years. Neurology 47: 889-894. |
| Библиографическая ссылка | Khan OAet al. (1996) Interferon beta-1b serum levels in multiple sclerosis patients following subcutaneous administration. Neurology 46: 1639-1643. |
| Библиографическая ссылка | Rudick RA. (1993) Multiple sclerosis. In: Johnson RT, Griffin JW (eds.). Current Therapy in Neurologic Disease. Mosby Year Book: St. Louis pp 158-163. |
| Библиографическая ссылка | Mulligan RC. (1993) The basic science of gene therapy. Science 260: 926-932. |
| Библиографическая ссылка | Sarvetnick. (1997) Mechanisms of cytokine-mediated localized immunoprotection. J Exp Med184: 1597-1600. |
| Библиографическая ссылка | Shaw MKet al. (1997) Local delivery of interleukin 4 by retrovirus-transduced T lymphocytes ameliorates experimental autoimmune encephalomyelitis. J Exp Med 185: 1711-1714. |
| Библиографическая ссылка | Mathisen PMet al. (1997) Treatment of experimental autoimmune encephalomyelitis with genetically modified memory T cells. J Exp Med 186: 159-164. |
| Библиографическая ссылка | Mueller R, Krahl T, Sarvetnick N. (1996) Pancreatic expression of interleukin-4 abrogates insulitis and autoimmune diabetes in nonobese diabetic (NOD) mice. J Exp Med 184: 1093-1099. |
| Библиографическая ссылка | Glorioso JC, DeLuca NA, Fink DJ. (1995) Development and application of herpes simplex virus vectors for human gene therapy. Annu Rev Microbiol 49: 675-710. |
| Библиографическая ссылка | Fink DJ, Glorioso JC. (1997) Engineering herpes simplex virus vectors for gene transfer to neurons. Nat Med 3: 357-359. |
| Библиографическая ссылка | Slack RS, Miller FD. (1996) Viral vectors for modulating gene expression in neurons. Curr Opin Neurobiol 6: 576-583. |
| Библиографическая ссылка | DeLuca NA, McCarthy AM, Schaffer PA. (1985) Isolation and characterization of deletion mutants of herpes simplex virus type 1 in the gene encoding immediate-early regulatory protein ICP4. J Virol 56: 558-570. |
| Библиографическая ссылка | Glorioso JC, Goins WF, DeLuca N, Fink DJ. (1994) Development of herpes simplex virus as a gene transfer vector for the nervous system. Gene Ther 1 (Suppl 1): S39-S39. |
| Библиографическая ссылка | Mendel I, Kerlero de Rosbo N, Ben-Nun A. (1995) A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2b mice: fine specificity and T cell receptor V beta expression of encephalitogenic T cells. Eur J Immunol 25: 1951-1959. |
| Библиографическая ссылка | Ueda H, Amano H, Shiomi H, Takagi H. (1979) Comparison of the analgesic effects of various opioid peptides by a newly devised intracisternal injection technique in conscious mice. Eur J Pharmacol 56: 265-268. |
